参考文献/References:
[1]Rennenberg RJ,Kessels AG,Schurgers LJ,et al. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis[J]. Vasc Health Risk Manag,2009,5(1):185-197.
[2]Han L,Zhang Y,Zhang M,et al. Interleukin-1β-Induced Senescence Promotes Osteoblastic Transition of Vascular Smooth Muscle Cells[J]. Kidney Blood Press Res,2020,45(2):314-330.
[3]Awan Z,Denis M,Roubtsova A,et al. Reducing Vascular Calcification by Anti-IL-1β Monoclonal Antibody in a Mouse Model of Familial Hypercholesterolemia[J]. Angiology,2016,67(2):157-167.
[4]Ceneri N,Zhao L,Young BD,et al. Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production[J]. Arterioscler Thromb Vasc Biol,2017,37(2):328-340.
[5]Shobeiri N,Bendeck MP. Interleukin-1β is a key biomarker and mediator of inflammatory vascular calcification[J]. Arterioscler Thromb Vasc Biol,2017,37(2):179-180.
[6]Sánchez-Duffhues G,García de Vinuesa A,van de Pol V,et al. Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2[J]. J Pathol,2019,247(3):333-346.
[7]Han L,Zhang Y,Zhang M,et al. Interleukin-1β-Induced senescence promotes osteoblastic transition of vascular smooth muscle cells[J]. Kidney Blood Press Res,2020,45(2):314-330.
[8]Yin Y,Zhou Z,Liu W,et al. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway[J]. Int J Biochem Cell Biol,2017,84:22-34.
[9]Callegari A,Coons ML,Ricks JL,et al. Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells:Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6[J]. J Vasc Res.,2014,51(2):118-131.
[10]Lee GL,Yeh C,Wu JY,et al. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction[J]. Arterioscler Thromb Vasc Biol,2019,39(3):432-445.
[11]Kurozumi A,Nakano K,Yamagata K,et al. IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2[J]. Bone,2019,124:53-61.
[12]Xu D,Zeng F,Han L,et al. The synergistic action of phosphate and interleukin-6 enhances senescence-associated calcification in vascular smooth muscle cells depending on p53[J]. Mech Ageing Dev,2019,182:111-124.
[13]Kienhorst LB,van Lochem E,Kievit W,et al. Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin-8 (CXCL8),Myeloid-Related Protein 8/Myeloid-Related Protein 14 Complex,and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease[J]. Arthritis Rheumatol.,2015,67(12):3303-3313.
[14]Bouabdallah J,Zibara K,Issa H, et al. Endothelial cells exposed to phosphate and indoxyl sulphate promote vascular calcification through interleukin-8 secretion[J]. Nephrol Dial Transplant.,2019,34(7):1125-1134.
[15]Orejudo M,García-Redondo AB,Rodrigues-Diez RR,et al. Interleukin-17A induces vascular remodeling of small arteries and blood pressure elevation[J]. Clin Sci?(Lond).,2020,134(5):513-527.
[16]Chang SF,Liu SF,Chen CN,et al. Serum IP-10 and IL-17 from Kawasaki disease patients induce calcification-related genes and proteins in human coronary artery smooth muscle cells in vitro[J]. Cell Biosci,2020,10:36.
[17]Wang Z,Tan J,Lei L,et al. The positive effects of secreting cytokines IL-17 and IFN-γ on the early-stage differentiation and negative effects on the calcification of primary osteoblasts in vitro[J]. Int Immunopharmacol.,2018,57:1-10.
[18]Schelski N,Luong TTD,Lang F,et al. SGK1-dependent stimulation of vascular smooth muscle cell osteo-/chondrogenic transdifferentiation by interleukin-18[J]. Pflugers Arch.,2019,471(6):889-899.
[19]Zhang K,Zhang Y,Feng W,et al. Interleukin-18 enhances vascular calcification and osteogenic differentiation of vascular smooth muscle cells through TRPM7 activation[J]. Arterioscler Thromb Vasc Biol,2017,37(10):1933-1943.
[20]Huo Y,Chu Y,Guo L,et al. Cortisol is associated with low frequency of interleukin 10-producing B cells in patients with atherosclerosis[J]. Cell Biochem Funct,2017,35(3):178-183.
[21]Rincón-Arévalo H,Quintero JC,Fortich F,et al. Low frequency of IL-10+ B cells in patients with atherosclerosis is related with inflammatory condition[J]. Heliyon,2020,6(3):e03441.
[22]Sage AP,Nus M,Baker LL,et al. Regulatory B cell-specific interleukin-10 is dispensable for atherosclerosis development in mice[J]. Arterioscler Thromb Vasc Biol,2015,35(8):1770-1773.
[23]Goldwater D,Karlamangla A,Merkin SS,et al. Interleukin-10 as a predictor of major adverse cardiovascular events in a racially and ethnically diverse population:Multi-Ethnic Study of Atherosclerosis[J]. Ann Epidemiol,2019,30:9-14.
[24]Lee KM,Kang HA,Park M,et al. Interleukin-24 attenuateβ-glycerophosphate-induced calcification of vascular smooth muscle cells by inhibiting apoptosis,the expression of calcification and osteoblastic markers,and the Wnt/β-catenin pathway[J]. Biochem Biophys Res Commun,2012,428(1):50-55.
[25]Lee KM,Kang HA,Ko CB,et al. Differential gene expression profiles in spontaneously hypertensive rats induced by administration of enalapril and nifedipine[J]. Int J Mol Med,2013,31(1):179-187.
[26]Kawada S,Nagasawa Y,Kawabe M,et al. Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24(IL-24),with/without TNF-alpha[J]. Sci Rep,2018,8(1):658.
[27]王庆航，陈越峰，陶琳琳，等. 白细胞介素35对ApoE-/-小鼠炎症及动脉粥样硬化的影响[J].中国动脉硬化杂志,2016,24(04):334-338.
[28]Li X,Fang P,Sun Y,et al. Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation,but spare innate immune memory signature in endothelial cells[J]. Redox Biol,2020,28:101373.
[29]Chai M,Ji Q,Zhang H,et al. The Protective Effect of Interleukin-37 on Vascular Calcification and Atherosclerosis in Apolipoprotein E-Deficient Mice with Diabetes[J]. J Interferon Cytokine Res,2015,35(7):530-539.
[30]Chai M,Zhang HT,Zhou YJ,et al. Elevated IL-37 levels in the plasma of patients with severe coronary artery calcification[J]. J Geriatr Cardiol,2017,14(5):285-291.
[31]Zhou P,Li Q,Su S,et al. Interleukin 37 Suppresses M1 Macrophage Polarization Through Inhibition of the Notch1 and Nuclear Factor Kappa B Pathways[J]. Front Cell Dev Biol.,2020,8:56.
[32]Yang Z,Kang L,Wang Y,et al. Role of IL-37 in cardiovascular disease inflammation[J]. Can J Cardiol,2019,35(7):923-930.